These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15056504)

  • 1. Drug dependence and addiction, III: Expectation and brain function in drug abuse.
    Volkow N
    Am J Psychiatry; 2004 Apr; 161(4):621. PubMed ID: 15056504
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction.
    Volkow ND; Wang GJ; Ma Y; Fowler JS; Wong C; Ding YS; Hitzemann R; Swanson JM; Kalivas P
    J Neurosci; 2005 Apr; 25(15):3932-9. PubMed ID: 15829645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Angrist B; Gatley SJ; Logan J; Ding YS; Pappas N
    Am J Psychiatry; 1999 Jan; 156(1):19-26. PubMed ID: 9892293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addiction and imaging of the living human brain.
    Gatley SJ; Volkow ND
    Drug Alcohol Depend; 1998; 51(1-2):97-108. PubMed ID: 9716933
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

  • 8. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute psychiatric symptoms during methylphenidate intravenous injections: A case report].
    Vérité F; Micallef J
    Therapie; 2017 Jun; 72(3):367-372. PubMed ID: 27988038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the neurochemistry of alcohol and substance abuse.
    Martinez D; Kim JH; Krystal J; Abi-Dargham A
    Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers.
    Volkow ND; Wang GJ; Ma Y; Fowler JS; Zhu W; Maynard L; Telang F; Vaska P; Ding YS; Wong C; Swanson JM
    J Neurosci; 2003 Dec; 23(36):11461-8. PubMed ID: 14673011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
    Nader MA; Czoty PW
    Am J Psychiatry; 2005 Aug; 162(8):1473-82. PubMed ID: 16055768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Di Chiara G
    Behav Pharmacol; 2002 Sep; 13(5-6):371-7. PubMed ID: 12394413
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional studies in substance abuse: imaging and beyond.
    Levin JM; Kaufman MJ
    J Nucl Med; 1995 Jul; 36(7):1298-300. PubMed ID: 7790959
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylphenidate: abuse and addiction.
    Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roman high- and low-avoidance rat lines differ in the acquisition, maintenance, extinction, and reinstatement of intravenous cocaine self-administration.
    Fattore L; Piras G; Corda MG; Giorgi O
    Neuropsychopharmacology; 2009 Apr; 34(5):1091-101. PubMed ID: 18418365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.
    Howell LL; Murnane KS
    Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.